Cliff Asness’s Celularity CELU Stock Holding History

Cliff Asness’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,410	Closed	-$79K	–	2210
2022 Q3	$79K	Buy	+3,410	New	+$103K	﹤0.01%	2125

Other funds holding CELU

SIC

Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Cliff Asness's CELU Position: Q4 2022 in Review

Cliff Asness sold out of Celularity (CELU) in Q4 2022, closing a stake of 3,410 shares — an estimated $79K sold.

Cliff Asness first reported a position in CELU in Q3 2022 and held it in 1 quarter. The position peaked at $79K in Q3 2022. 73 funds tracked by Wall St. Rank hold CELU as of Q4 2022.

Cliff Asness reported no remaining Celularity position as of Q4 2022 after selling out during the quarter.
Cliff Asness sold 3,410 Celularity shares in Q4 2022, an estimated $79K.
Cliff Asness first reported a position in Celularity in Q3 2022 and held it in 1 quarter.
Cliff Asness's Celularity position peaked at $79K in Q3 2022.
73 funds tracked by Wall St. Rank held Celularity as of Q4 2022.

Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.